71364 Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 

years of age. FMB&M–IFPS III will be a 

longitudinal study of pregnant women 

and their new baby for two years. 

Throughout the study planning period, 

CDC engaged with subject matter 

experts from multiple Federal agencies 

including the National Institutes of 

Health (NIH), the U.S. Department of 

Agriculture (USDA), and the Food and 

Drug Administration (FDA) to ensure 

that FMB&M–IFPS III applies lessons 

learned from previous studies and 

represents the priorities and needs of 

numerous stakeholders. The new study 

design is based on updated 

methodology and questions, and 

recruitment of a new cohort of study 

participants. 

CDC will collect information about 

mother’s intentions, behaviors, feeding 

decisions, and practices from pregnancy 

through their child’s first two years of 

life and how these change; child health 

outcomes; and emerging issues related 

to infant and toddler feeding practices. 

Data will be collected using web-based 

surveys at multiple time points. This 

includes: (1) a prenatal survey; (2) 14 

follow-up surveys after the baby is born; 

and (3) 2–4 maternal dietary data 

recalls. CDC estimates that 7,477 

pregnant women, ages 18–49, must be 

screened in order to obtain complete 

data on 2,500 study participants. The 

goal is to recruit equal proportions of 

non-Hispanic white, non-Hispanic 

black, and Hispanic participants. An 

OMB Extension is requested for one 

year. CDC requests OMB approval for an 

estimated 5,051 annualized burden 

hours. Participation is voluntary, and 

there are no costs to respondents other 

than their time. 

Estimated Annualized Burden Hours 

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Pregnant/Postpartum Women ......................... Study Screener ..............................................

Study Consent ................................................

2,492 

1,570 

1 

1 

3/60 

5/60 

Prenatal Survey .............................................. 1,413 1 20/60 

24-Hour Dietary Recall—Prenatal .................. 919 1 24/60 

Replicate 24-Hour Dietary Recall—Prenatal 90 1 24/60 

Request for notification of child’s birth ........... 1,413 1 2/60 

Birth Screener ................................................ 1,368 1 2/60 

1-Month Survey .............................................. 1,231 1 20/60 

2-Month Survey .............................................. 1,192 1 15/60 

3-Month Survey .............................................. 1,153 1 15/60 

24-Hour Dietary Recall—Month 3 .................. 750 1 24/60 

Replicate 24-Hour Dietary Recall—Month 3 .. 73 1 24/60 

4-Month Survey .............................................. 1,117 1 15/60 

5-Month Survey .............................................. 1,081 1 15/60 

6-Month Survey .............................................. 1,046 1 15/60 

8-Month Survey .............................................. 1,013 1 15/60 

10-Month Survey ............................................ 980 1 20/60 

12-Month Survey ............................................ 949 1 15/60 

15-Month Survey ............................................ 919 1 15/60 

18-Month Survey ............................................ 889 1 15/60 

21-Month Survey ............................................ 861 1 15/60 

24-Month Survey ............................................ 833 1 15/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2023–22780 Filed 10–13–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–24–1316; Docket No. CDC–2023– 

0084] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Aerosols from 

Harmful Algal Blooms: Exposures and 

Health Effects in Highly Exposed 

Populations. The goal of this study is to 

conduct exploratory analyses of the 

relationships between HAB-related 

biomonitoring data, environmental data, 

and symptom reporting. 

DATES: CDC must receive written 

comments on or before December 15, 

2023. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2023– 

0084 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 71365 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Aerosols from Harmful Algal Blooms: 

Exposures and Health Effects in Highly 

Exposed Populations (OMB Control No. 

0920–1316, Exp. 1/31/2024)— 

Extension—National Center for 

Environmental Health (NCEH), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

Human exposures to HAB toxins 

(harmful algal blooms, or HABS, 

include marine microalgae; marine 

macroalgae, such as seaweeds; and 

cyanobacteria, also called blue-green 

algae) have been reported to produce a 

variety of health effects, including 

respiratory irritation and liver and 

kidney damage. The goal of this study 

is to conduct exploratory analyses of the 

relationships between biomonitoring 

data, environmental data, and symptom 

reporting. CDC anticipates this research 

to be hypothesis generating, and not 

necessarily generalizable to participants 

with similar exposures in the same 

population or to the public more 

generally. 

HABs and associated environmental 

impacts (e.g., geographic and temporal 

extent, composition, toxin production) 

are difficult, if not impossible to predict 

and track. This project was developed in 

response to community health concerns 

reported during a severe cyanobacterial 

bloom in 2018. Since then, there have 

not been any significant blooms, and 

CDC has been unable to implement the 

study. As such, during the first three 

years of approval for this data 

collection, CDC was unable to align the 

physical occurrence of a specific type of 

HAB, a cyanobacterial bloom, of 

significant magnitude with government 

approvals and resource commitments. 

The program requests an Extension of 

OMB approval to allow us to implement 

the study during the next substantial 

HAB that occurs in Florida whether it 

comprises cyanobacteria, marine 

microalgae, or seaweed. 

The total number of respondents is 

486, which is unchanged from the 

previously approved number of 

respondents. The total estimated 

annualized time burden is 1,273 hours. 

Participation is voluntary and there are 

no costs to respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

(in hours) 

Interested community members ....... Screening/baseline Survey .............. 84 1 15/60 21 

Eligible study respondents ................ Symptom Survey .............................. 67 10 15/60 167 

Eligible study respondents ................ Record of Time Spent Outdoors ...... 67 5 10/60 56 

Eligible study respondents ................ Provide blood specimen ................... 67 3 15/60 51 

Eligible study respondents ................ Provide specimens (urine, nasal 

swabs, lung function test).

67 10 1 670 

Eligible study respondents ................ Be outfitted with personal air sampler.67 5 45/60 252 

Eligible study respondents ................ Provide fish (if respondent went 

fishing and caught fish).

67 5 10/60 56 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,273 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–22779 Filed 10–13–23; 8:45 am] 

BILLING CODE 4163–18–P 


ddrumheller on DSK120RN23PROD with NOTICES1